HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rob Scott Selected Research

Coronary Artery Disease (Coronary Atherosclerosis)

3/2008Effects of the antioxidant succinobucol (AGI-1067) on human atherosclerosis in a randomized clinical trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Rob Scott Research Topics

Disease

8Cardiovascular Diseases (Cardiovascular Disease)
01/2018 - 11/2013
6Hypercholesterolemia
06/2014 - 01/2014
3Myalgia
06/2016 - 12/2012
3Coronary Disease (Coronary Heart Disease)
04/2016 - 11/2014
3Dyslipidemias (Dyslipidemia)
01/2016 - 04/2014
2Atherosclerosis
11/2014 - 03/2008
2Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
11/2013 - 11/2012
1Insulin Resistance
01/2017
1Skeletal Abnormalities Mandibular Hypoplasia Auditory Canal Atresia Short Stature
06/2016
1Coinfection
01/2016
1Hepatitis C
01/2016
1Nasopharyngitis
01/2015
1Arthralgia (Joint Pain)
05/2014
1Headache (Headaches)
05/2014
1Back Pain (Backache)
05/2014
1Pain (Aches)
05/2014
1Spasm (Spasms)
05/2014
1Hyperlipidemias (Hyperlipidemia)
05/2014
1Myositis (Idiopathic Inflammatory Myopathies)
03/2014
1Rhabdomyolysis
03/2014
1Muscular Diseases (Myopathy)
03/2014
1Homozygous Familial Hypercholesterolemia
11/2013
1Inflammation (Inflammations)
01/2009
1Retinal Detachment (Retinal Detachments)
01/2009
1Coronary Artery Disease (Coronary Atherosclerosis)
03/2008

Drug/Important Bio-Agent (IBA)

12oxidized low density lipoproteinIBA
01/2018 - 11/2012
11evolocumabIBA
06/2016 - 11/2012
7Ezetimibe (Zetia)FDA Link
06/2016 - 11/2012
7Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
06/2016 - 11/2012
7LDL CholesterolIBA
01/2016 - 11/2012
3LDL Lipoproteins (beta Lipoproteins)IBA
01/2018 - 11/2013
3Monoclonal AntibodiesIBA
06/2016 - 11/2012
3CholesterolIBA
03/2016 - 05/2014
2Apoprotein(a) (Apolipoprotein (a))IBA
01/2018 - 04/2014
2Cardiovascular AgentsIBA
08/2017 - 04/2015
2Apolipoproteins E (ApoE)IBA
01/2017 - 11/2014
2Proprotein Convertase 9IBA
06/2016 - 11/2012
2Atorvastatin (Lipitor)FDA Link
04/2016 - 03/2016
2Proprotein Convertases (Pro-Opiomelanocortin Converting Enzyme)IBA
01/2016 - 11/2013
2SubtilisinIBA
01/2016 - 11/2013
1Apolipoproteins AIBA
01/2018
1Lipoprotein(a)IBA
01/2018
1Lipoprotein Lipase (Diacylglycerol Lipase)IBA
01/2017
1Proteins (Proteins, Gene)FDA Link
01/2017
1Cholesterol Esters (Cholesteryl Esters)IBA
01/2017
1Creatine Kinase (Creatine Phosphokinase)IBA
03/2016
1LipidsIBA
01/2016
1PlasminogenIBA
04/2014
1Glycoproteins (Glycoprotein)IBA
04/2014
1LDL Receptors (LDL Receptor)IBA
11/2013
1Serine Proteases (Serine Protease)IBA
11/2012
1MiragelIBA
01/2009
1AntioxidantsIBA
03/2008
1succinobucol (AGI 1067)IBA
03/2008

Therapy/Procedure

8Therapeutics
08/2017 - 11/2012
1Drug Therapy (Chemotherapy)
11/2013
1Percutaneous Coronary Intervention
03/2008